Perineural Therapy Market Size

  • Report ID: 4161
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Perineural Therapy Market Size

Perineural Therapy Market size was over USD 346.2 Million in 2023 and is set to cross USD 2.22 Billion by the end of 2036, growing at more than 15.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of perineural therapy is estimated at USD 394.18 Million. The increasing prevalence of different neural disorders is anticipated to propel the growth of the market during the forecast period. As per the data provided by Pan American Health Organization (PAHO), in the U.S., 533,172 individuals lost their lives due to neurological conditions, out of which, 213,129 were men and 320,043 were women in 2019.

The global perineural therapy market is further estimated to witness growth on the back of the increment in approval and launch of more enhanced drugs and other products to repair and regenerate nerves. In a study conducted by the National Library of Medicine in 2020, it was observed that around 82% meaningful recovery (MR) was obtained from mixed, sensory, and motor nerve repair having almost 70 mm gaps. There were no significant differences in MR across the nerve type, age, time to repair, and smoking status, however, significant differences were noted by the injury type. complex injuries had 74% MR as compared to lacerations at 85%, and neuroma resections at 94% recovery.


Perineural Therapy Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4161
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of perineural therapy is estimated at USD 394.18 Million.

The perineural therapy market size was over USD 346.2 Million in 2023 and is set to cross USD 2.22 Billion by the end of 2036, growing at more than 15.4% CAGR during the forecast period i.e., between 2024-2036. The higher prevalence of different sorts of neural disorders and the increment in approval of more enhanced products to repair and regenerate nerves are the major factors driving the market growth.

North America is projected to account for majority industry share by 2036, on the back of a higher prevalence of sports injuries.

Boston Scientific Corporation, tVNS Technologies GmbH, Abbott Laboratories, NeuroSigma, Inc., Axogen Corporation, BioWave Limited, Baxter Healthcare Corporation, LivaNova, PLC, Integra LifeSciences Corporation, Soterix Medical, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample